| Date Filed | Type | Description |
| 08/21/2023 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 14,876 shares
@ $10.7288, valued at
$159.6k
Exercised 6,944 restricted stock units
@ $0
Exercised 5,805 restricted stock units
@ $0
Exercised 20,833 rights
@ $0 |
|
| 05/22/2023 |
4/A
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Exercised 6,944 options to buy
@ $0 |
|
| 05/19/2023 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 5,627 shares
@ $10.1444, valued at
$57.1k
Granted 83,334 restricted stock units
@ $0
Exercised 6,945 restricted stock units
@ $0
Exercised 5,805 restricted stock units
@ $0 |
|
| 02/23/2023 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 6,700 shares
@ $7.66, valued at
$51.3k
Exercised 6,944 options to buy
@ $0
Exercised 5,805 restricted stock units
@ $0 |
|
| 11/21/2022 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 1,785 shares
@ $5.44, valued at
$9.7k
Exercised 5,805 restricted stock units
@ $0 |
|
| 09/07/2022 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Gifted 6,500 shares
@ $0
Sold 1,320 shares
@ $17.0134, valued at
$22.5k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/18/2020 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 140,000 options to buy
@ $10.2, valued at
$1.4M
|
|
| 10/22/2020 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 11,218 shares
@ $17.2746, valued at
$193.8k
Sold 4,776 shares
@ $18.005, valued at
$86k
Sold 5,800 shares
@ $17.4849, valued at
$101.4k
Sold 13,052 shares
@ $18.5137, valued at
$241.6k
Sold 3,693 shares
@ $19.0072, valued at
$70.2k
|
|
| 10/20/2020 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 1,261 shares
@ $17.0056, valued at
$21.4k
Gifted 3,000 shares
@ $0 |
|
| 02/07/2020 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 200 shares
@ $17.05, valued at
$3.4k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 100 shares
@ $17, valued at
$1.7k
Sold 2,200 shares
@ $17.062, valued at
$37.5k
Sold 5,400 shares
@ $17.0585, valued at
$92.1k
|
|
| 07/17/2019 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 10,000 shares
@ $17.0407, valued at
$170.4k
|
|
| 05/17/2019 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 67,500 options to buy
@ $24.23, valued at
$1.6M
|
|
| 04/23/2019 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 9,700 shares
@ $24.7609, valued at
$240.2k
Sold 300 shares
@ $25.9233, valued at
$7.8k
|
|
| 03/15/2019 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 3,000 shares
@ $30.1613, valued at
$90.5k
|
|
| 01/16/2019 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Sold 9,099 shares
@ $19.2804, valued at
$175.4k
Sold 901 shares
@ $19.8623, valued at
$17.9k
|
|
| 09/20/2018 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 150,000 options to buy
@ $16.08, valued at
$2.4M
|
|
| 06/06/2018 |
4
| Crockett Thomas Andrew (CEO) has filed a Form 4 on KalVista Pharmaceuticals, Inc.|
Txns:
| Granted 130,800 options to buy
@ $8.21, valued at
$1.1M
|
|
| 05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/28/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |